FDA Taps IOM To Study Premarket Approval Process
The Institute of Medicine has been commissioned by the U.S. Food and Drug Administration to scrutinize the premarket notification program under which certain medical devices marketed in the U.S. are reviewed...To view the full article, register now.
Already a subscriber? Click here to view full article